Clinical Trial Results:
A prospective, multicenter, double-blind, randomized, placebo-controlled, two-parallel groups Phase IIIb clinical study, to assess the efficacy and safety of adding low doses of hCG at a short IVF protocol with GnRH agonist and controlled ovular stimulation with recombinant FSH (rFSH) at the beginning of the follicular phase and during the whole stimulation period in infertile women of older age who are undergoing IVF, on the number of embryos to be transferred
Summary
|
|
EudraCT number |
2016-005208-24 |
Trial protocol |
GR |
Global completion date |
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
07 Sep 2021
|
First version publication date |
07 Sep 2021
|
Other versions |
|
Summary report(s) |
2016-005208-24 for EUDRACT |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.